Dan Eik Høfsten

Dan Eik Høfsten

Clinical Associate Professor

Member of:

  • Internal medicine: Cardiology


  1. 2018
  2. Published

    Cochrane corner: complete versus culprit-only revascularisation in ST segment elevation myocardial infarction with multivessel disease

    Bravo, C. A., Hirji, S. A., Bhatt, D. L., Gluud, C., Faxon, D. P., Ohman, E. M., Kaneko, T., Engstrøm, Thomas, Høfsten, Dan Eik & Brennan, J. M., 2018, In: Heart. 104, 14, p. 1144-1147 4 p.

    Research output: Contribution to journalLetterResearchpeer-review

  3. Published

    Comparison between patients included in randomized controlled trials of ischemic heart disease and real-world data. A nationwide study

    Laursen, P. N., Holmvang, Lene, Lønborg, J., Køber, Lars Valeur, Høfsten, Dan Eik, Helqvist, S., Clemmensen, P., Kelbæk, H., Jørgensen, E., Lassen, J. F., Pedersen, F., Høi-Hansen, T., Therkelsen, C. J., Tilsted, H., Jensen, L. O., Nepper-Christensen, L., Sadjadieh, G. & Engstrøm, Thomas, 2018, In: American Heart Journal. 204, p. 128-138 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Impact of diagnostic ECG-to-wire delay in STEMI patients treated with primary PCI: a DANAMI-3 substudy

    Nepper-Christensen, L., Lønborg, Jacob Thomsen, Høfsten, Dan Eik, Ahtarovski, K. A., Kyhl, K., Göransson, C., Køber, Lars Valeur, Helqvist, S., Pedersen, F., Kelbæk, H., Vejlstrup, N., Holmvang, Lene & Engstrøm, Thomas, 2018, In: EuroIntervention. 14, 6, p. 700-707 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    MR-proADM as a Prognostic Marker in Patients With ST-Segment-Elevation Myocardial Infarction - DANAMI-3 (a Danish Study of Optimal Acute Treatment of Patients With STEMI) Substudy

    Falkentoft, A. C., Rørth, R., Iversen, Kasper, Høfsten, Dan Eik, Kelbæk, H., Holmvang, Lene, Frydland, M., Schoos, M. M., Helqvist, S., Axelsson, A., Clemmensen, P., Jørgensen, E., Saunamäki, K., Tilsted, H., Pedersen, F., Torp-Pedersen, C., Kofoed, Klaus Fuglsang, Goetze, Jens P. , Engstrøm, Thomas & Køber, Lars Valeur, 2018, In: Journal of the American Heart Association. 7, 11, p. 1-13 e008123.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Prognostic Value of the Residual SYNTAX Score After Functionally Complete Revascularization in ACS

    Kobayashi, Y., Lønborg, J., Jong, A., Nishi, T., De Bruyne, B., Høfsten, Dan Eik, Kelbæk, H., Layland, J., Nam, C., Pijls, N. H. J., Tonino, P. A. L., Warnøe, J., Oldroyd, K. G., Berry, C., Engstrøm, Thomas, Fearon, W. F. & DANAMI-3-PRIMULTI, FAME, and FAMOUS-NSTEMI Study Investigators, D. F. A. F. S. I., 2018, In: Journal of the American College of Cardiology. 72, 12, p. 1321-1329 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    The Glucagon-Like Peptide-1 Analog Exenatide Increases Blood Glucose Clearance, Lactate Clearance, and Heart Rate in Comatose Patients After Out-of-Hospital Cardiac Arrest

    Wiberg, S., Kjaergaard, J., Schmidt, H., Thomsen, J. H., Frydland, M., Winther-Jensen, M., Lindholm, M. G., Høfsten, Dan Eik, Engstrøm, Thomas, Køber, Lars Valeur, Møller, J. E. & Hassager, Christian, 2018, In: Critical Care Medicine. 46, 2, p. e118-e125 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Benefit From Reperfusion With Primary Percutaneous Coronary Intervention Beyond 12 Hours of Symptom Duration in Patients With ST-Segment-Elevation Myocardial Infarction

    Nepper-Christensen, L., Lønborg, J., Høfsten, Dan Eik, Ahtarovski, K. A., Bang, L. E., Helqvist, S., Kyhl, K., Køber, Lars Valeur, Kelbæk, H., Vejlstrup, N., Holmvang, Lene & Engstrøm, Thomas, Sep 2018, In: Circulation: Cardiovascular Interventions. 11, 9, p. 1-9 e006842.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Can copeptin and troponin T ratio predict final infarct size and myocardial salvage index in patients with ST-elevation myocardial infarction: A sub-study of the DANAMI-3 trial

    Árnadóttir, Á., Schoos, M., Lønborg, J., Ahtarovski, K., Kelbæk, H., Helqvist, S., Høfsten, Dan Eik, Clemmensen, P., Engstrøm, Thomas, Nepper-Christensen, L., Vejlstrup, N., Køber, Lars Valeur & Iversen, Kasper, Sep 2018, In: Clinical Biochemistry. 59, p. 37-42 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Early Versus Standard Care Invasive Examination and Treatment of Patients With Non-ST-Segment Elevation Acute Coronary Syndrome: VERDICT Randomized Controlled Trial

    Kofoed, K. F., Kelbæk, H., Hansen, P. R., Torp-Pedersen, C., Høfsten, D., Kløvgaard, L., Holmvang, L., Helqvist, S., Jørgensen, E., Galatius, S., Pedersen, F., Bang, L., Saunamaki, K., Clemmensen, P., Linde, J. J., Heitmann, M., Wendelboe Nielsen, O., Raymond, I. E., Kristiansen, O. P., Svendsen, I. H. & 18 others, Bech, J., Dominguez, Helena, Kragelund, C., Hansen, T. F., Hove, Jens Dahlgaard, Jørgensen, T., Fornitz, Gitte Gleerup, Steffensen, R., Jurlander, B., Abdulla, J., Lyngbæk, S., Elming, H., Therkelsen, S. K., Abildgaard, U., Jensen, J. S., Gislason, Gunnar Hilmar, Køber, Lars Valeur & Engstrøm, Thomas, 11 Dec 2018, In: Circulation. 138, 24, p. 2741-2750 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. 2019
  12. Published

    Clinical characteristics and lipid lowering treatment of patients initiated on proprotein convertase subtilisin-kexin type 9 inhibitors: a nationwide cohort study

    Jensen, J. S., Weeke, P. E., Bang, L. E., Høfsten, Dan Eik, Ripa, M. S., Schjerning, A., Theilade, Juliane, Køber, Lars Valeur, Gislason, Gunnar Hilmar & Pallisgaard, J., 2019, In: BMJ Open. 9, 7 p., e022702.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 3 4 5 6 7 Next

ID: 211200058